Search these posts for articles, publications, research studies & discussions relevant to Phoenix Micron products.

Phoenix MICRON Research Blog

2024

Your Guide to Navigating Seattle for ARVO 2024

We’re excited to see everyone at ARVO 2024 in Seattle in May! Every year, we are impressed and humbled by the incredible presentations and posters that highlight breakthrough research related to new disease models, diagnostics, and therapies. Phoenix-Micron is headquartered in the Northwest, and many of our team members are either from the Seattle area

2024

Phoenix-Micron, Inc. Announces Exclusive North American Distribution of Striatech Products

Phoenix extends its product offerings in North America to include behavioral assays to evaluate the visual abilities of rodents   Bend, OR, USA, January 25, 2024  – Phoenix-Micron, Inc. (“Phoenix”), recognized globally for its leadership in in vivo ophthalmic imaging of small animals, is proud to unveil its latest collaboration as the exclusive North American

2023

Exploring the Intersection of Art and Retinal Research: A Journey of Discovery

Our latest blog post veers from the traditional focus on a singular research paper to bring you an enthralling narrative at the crossroads of progressive inherited retinal dystrophy (IRD), the frigid expanses of Antarctica, marathon endurance, the expressive world of art, and the transformative realm of retinal research. This story encompasses gene editing, animal models,

2023

Small zebrafish are impressive, effective models for studying endotoxin induced uveitis

Researchers at Henan Province Eye Hospital in China have made great strides in studying endotoxin-induced uveitis (EIU) by creating a novel EIU model in zebrafish.  Uveitis is an ocular inflammation and one of the main causes of visual impairment, accounting for 10-15% of global blindness.  Mice have typically been the research animal of choice however

2023

Researchers find early signs of Alzheimer’s disease (AD) in the mouse retina and develop a non-invasive artificial intelligence-based system that could be used to diagnose the disease before the appearance of clinical symptoms

Progress in diagnosing and treating Alzheimer’s disease (AD) has been accelerating over the last few years. Until now, AD has been difficult to diagnose. The disease can be present years before distinguishable symptoms manifest. Non-invasive diagnostic tests have been lacking, and diagnosis often relies on memory, cognitive, and behavioral tests. In 2011, Koronyo-Hamaoui M, Koronyo

2023

Phoenix-Micron, Inc. launches the next generation of its MICRON in vivo ophthalmic imaging platform for small animal research

The all-new MICRON® 5 platform delivers advanced performance, repeatability, and imaging workflow efficiency Bend, OR, USA, April 21, 2023 – Phoenix-Micron, Inc. today announced the launch of the all-new Phoenix MICRON® 5 imaging system, the latest breakthrough in small animal ophthalmic imaging technology. With over 450 published studies utilizing MICRON imaging systems, the MICRON platform

1 2 3 9